Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cell Mol Neurobiol. 2011 May 21;31(7):1057–1069. doi: 10.1007/s10571-011-9705-2

Fig. 6.

Fig. 6

Effect of ephrinA1 expression blockade in locomotor behaviors. a Infusion of 5 nmol antisense (AS) oligonucleotide blocked basal ephrinA1 expression after SCI and significantly reduced BBB scores at all time points when compared to rats infused with scramble (SCR) control oligonucleotides. b A parallel result was observed as the number of errors increased in the grid-walking test when animals were intrathecally infused with 5 nmol of ephrinA1 AS oligonucleotides. Significant scores were observed 14, 21, and 28 DPI when compared to rats infused with SCR control oligonucleotides (ANOVA followed by a Bonferroni post hoc test, P < 0.01, n = 8). The bars represent the mean ± standard error of the mean